Abstract-High-dose intravenous immunoglobulin (HD-IVIG) has temporary but reliable ef cacy in idiopathic thrombocytopenic purpura (ITP). HD-IVIG has been described as the representative management in pregnant cases of refractory to corticosteroid or immunosuppressants. There have been few cases treated with repeated HD-IVIG to sustain pregnancy from the early phase of pregnancy. This case report describes a pregnant case of steroid-refractory ITP, treated with six times repeated HD-IVIG, resulting in the successful delivery of a healthy newborn with a normal platelet count. No adverse effects were observed.
INTRODUCTION
Idiopathic thrombocytopenic purpura (ITP) often affects females of child-bearing age, so that the association of ITP and pregnancy is of special therapeutic signicance. High-dose intravenous immunoglobulin (HD-IVIG) has been often utilized for pregnant ITP patients, to prevent massive haemorrhage at delivery [1] . However, few cases have been treated with repeated HD-IVIG to avoid miscarriage from the early phase of pregnancy. We report here a pregnant case with steroid-refractory ITP, who was given HD-IVIG six times.
¤ To whom correspondence should be addressed at First Department of Internal Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho Kamigyo-ku, Kyoto 602-0841, Japan. Phone: +81-75-251-5505. Fax: +81-75-252-3721. E-mail: kobataka@koto.kpu-m.ac.j p A Japanese female patient had been suffering from severe chronic ITP since she was 15 years old. She had refused a splenectomy and was given 10 mg/day of prednisolone and 100 mg/day of oxymetholone, resulting in a platelet count of around 20 £ 10 9 per l. She stopped taking oxymetholone to become pregnant. She was impregnated but suffered a miscarriage at 8 weeks' gestation when she was 29 years old, at which time her platelet count was 7 £ 10 9 per l. She wanted another pregnancy and the dose of prednisolone was increased to 30 mg/day. Her second pregnancy was con rmed at 5 weeks' gestation and the platelet count was maintained at over 20 £ 10 9 per l until 18 weeks, when her platelet count fell to 6 £ 10 9 per l and intractable genital bleeding was observed. To prevent miscarriage, one course of HD-IVIG administration (Venilon ® , Teijin, Tokyo, Japan) at 400 mg/kg per day for three consecutive days was begun from 20 weeks, in addition to 30 mg/day of prednisolone. As a result, the platelet count rose to over 30 £ 10 9 per l. The ef cacy of HD-IVIG was temporary. Six administrations of HD-IVIG were required every 3 weeks. No bleeding was observed after the administration of HD-IVIG. When the patient suffered placental dysfunction at 36 weeks, she received 30 U of platelet transfusion and delivered a healthy newborn (1 min Apgar score 8, body weight 2480 g) by emergency Caesarean section. At delivery, the platelet counts of the mother and newborn were 96£ 10 9 and 200£ 10 9 per l, respectively (Fig. 1 ). Blood loss during the Caesarean section was 400 ml.
DISCUSSION
The American Society of Hematology guidelines indicates that management of maternal thrombocytopenia does not differ from that of non-pregnant patients [2] . Further treatments for ITP in addition to prednisolone were necessary for our patient because of an extremely low platelet count and genital bleeding. Repeated HD-IVIG had to be used in this case because the patient was refractory to prednisolone. 
